Depomed cutting one-fourth of staff

Menlo Park-based pharmaceutical firm Depomed Inc. (DEPO), is making staff cuts affecting approximately one-fourth of its staff following disappointing results in a phase 3 study in postherpetic neuralgia.

The company has two products on the market and other candidates in its development pipelines and holds proprietary drug delivery technology for the improvement of oral medications.

businessBusiness & Real Estate

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

CCSF puts Fort Mason campus on the chopping block

Faced with severe budget cuts, community college preparing to end decades-long lease

Neighbors sue city over safe camping site planned for Stanyan Street

A group of Haight residents filed a lawsuit Tuesday asking a federal… Continue reading

Man accused of killing 94-year-old Glen Park resident has troubled past

Neighbors had complained about ‘paranoid and aggressive behavior’

Newsom says rules for reopening California fitness centers coming ‘in a week or so’

By Phil Willon Los Angeles Times Gov. Gavin Newsom on Wednesday said… Continue reading

Fishermen, port struggling to recover from Pier 45 fire

Loss to fishing industry alone could be in the millions

Most Read